Age-related alterations affect the susceptibility of mice to prion infection

Neurobiology of Aging

Volumn 32, Issue 11, 2011, Pages 2006-2015

  Avrahami, Dana ^a   Gabizon, Ruth ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Age related; Aging; CJD; Gene expression; Incubation period; Inflammation; Neurodegeneration; Prion infection; PrP; Scrapie

Indexed keywords

PRION PROTEIN;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GLIOSIS; INCUBATION TIME; INFLAMMATION; MOUSE; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; STRESS; UPREGULATION;

AGE FACTORS; AGING; ANIMALS; BRAIN; DISEASE SUSCEPTIBILITY; FEMALE; MICE; PRION DISEASES; PRIONS;

EID: 80052617393     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.12.015     Document Type: Article

References (73)

1. Avrahami D., Dayan-Amouyal Y., Tal S., Mincberg M., Davis C., Abramsky O., Gabizon R. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells. J. Neurosci. Res. 2008, 86(12):2753-2762.
2. Beekes M., McBride P.A., Baldauf E. Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J. Gen. Virol. 1998, 79(Pt 3):601-607.
3. Bellinger D.L., Ackerman K.D., Felten S.Y., Felten D.L. A longitudinal study of age-related loss of noradrenergic nerves and lymphoid cells in the rat spleen. Exp. Neurol. 1992, 116(3):295-311.
4. Bencsik A., Lezmi S., Baron T. Autonomic nervous system innervation of lymphoid territories in spleen: a possible involvement of noradrenergic neurons for prion neuroinvasion in natural scrapie. J. Neurovirol. 2001, 7(5):447-453.
5. Beringue V., Adjou K.T., Lamoury F., Maignien T., Deslys J.P., Race R., Dormont D. Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent. J. Virol. 2000, 74(12):5432-5440.
6. Betmouni S., Perry V.H., Gordon J.L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 1996, 74(1):1-5.
7. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8(1):57-69.
8. Blumenthal H.T. Fidelity assurance mechanisms of the brain with special reference to its immunogenic CNS compartment: their role in aging and aging-associated neurological disease. J. Gerontol. A: Biol. Sci. Med. Sci. 1997, 52(1):B1-9.
9. Boelle P.Y., Cesbron J.Y., Valleron A.J. Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect. Dis. 2004, 4:26.
10. Bohr V.A., Ottersen O.P., Tonjum T. Genome instability and DNA repair in brain, ageing and neurological disease. Neuroscience 2007, 145(4):1183-1186.
11. Booth S., Bowman C., Baumgartner R., Sorensen G., Robertson C., Coulthart M., Phillipson C., Somorjai R.L. Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J. Gen. Virol. 2004, 85(Pt 11):3459-3471.
12. Brown D.R., Schmidt B., Kretzschmar H.A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 1996, 380(6572):345-347.
13. Brown P., Gibbs C.J., Rodgers-Johnson P., Asher D.M., Sulima M.P., Bacote A., Goldfarb L.G., Gajdusek D.C. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 1994, 35(5):513-529.
14. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 2002, 70(3):462-473.
15. Collinge J., Sidle K.C., Meads J., Ironside J., Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996, 383(6602):685-690.
16. Colombo G., Meli M., Morra G., Gabizon R., Gasset M. Methionine sulfoxides on prion protein Helix-3 switch on the alpha-fold destabilization required for conversion. PLoS One 2009, 4(1):e4296.
17. de Magalhaes J.P., Curado J., Church G.M. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009, 25(7):875-881.
18. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F. Neurotoxicity of a prion protein fragment. Nature 1993, 362(6420):543-546.
19. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128(1):92-105.
20. Fraser H., Dickinson A.G. Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J. Comp. Pathol. 1978, 88(4):563-573.
21. Friedman-Levi Y., Ovadia H., Hoftberger R., Einstein O., Abramsky O., Budka H., Gabizon R. Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis. J. Virol. 2007, 81(18):9942-9949.
22. Gajdusek D.C., Zigas V. Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. N. Engl. J. Med. 1957, 257(20):974-978.
23. Ghani A.C., Ferguson N.M., Donnelly C.A., Anderson R.M. Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK. Proc. Biol. Sci. 2003, 270(1516):689-698.
24. Gibbs C.J., Joy A., Heffner R., Franko M., Miyazaki M., Asher D.M., Parisi J.E., Brown P.W., Gajdusek D.C. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N. Engl. J. Med. 1985, 313(12):734-738.
25. Giese A., Brown D.R., Groschup M.H., Feldmann C., Haist I., Kretzschmar H.A. Role of microglia in neuronal cell death in prion disease. Brain Pathol. (Zurich, Switzerland) 1998, 8(3):449-457.
26. Glatzel M., Heppner F.L., Albers K.M., Aguzzi A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 2001, 31(1):25-34.
27. Harmey J.H., Doyle D., Brown V., Rogers M.S. The cellular isoform of the prion protein, PrPc, is associated with caveolae in mouse neuroblastoma (N2a) cells. Biochem. Biophys. Res. Commun. 1995, 210(3):753-759.
28. Haviv Y., Avrahami D., Ovadia H., Ben-Hur T., Gabizon R., Sharon R. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin. Arch. Neurol. 2008, 65(6):762-775.
29. Hetz C., Russelakis-Carneiro M., Maundrell K., Castilla J., Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 2003, 22(20):5435-5445.
30. Hilton D.A., Fathers E., Edwards P., Ironside J.W., Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998, 352(9129):703-704.
31. Hilton D.A., Sutak J., Smith M.E., Penney M., Conyers L., Edwards P., McCardle L., Ritchie D., Head M.W., Wiley C.A., Ironside J.W. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J. Clin. Pathol. 2004, 57(3):300-302.
32. Hinman J.D., Chen C.D., Oh S.Y., Hollander W., Abraham C.R. Age-dependent accumulation of ubiquitinated 2',3'-cyclic nucleotide 3'-phosphodiesterase in myelin lipid rafts. Glia 2008, 56(1):118-133.
33. Ironside J.W. Review: Creutzfeldt-Jakob disease. Brain Pathol. (Zurich, Switzerland) 1996, 6(4):379-388.
34. Jeffrey M., Martin S., Barr J., Chong A., Fraser J.R. Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J. Comp. Pathol. 2001, 124(1):20-28.
35. Jiang L., Fang J., Moore D.S., Gogichaeva N.V., Galeva N.A., Michaelis M.L., Zaidi A. Age-associated changes in synaptic lipid raft proteins revealed by two-dimensional fluorescence difference gel electrophoresis. Neurobiol. Aging 2008.
36. Kempster S., Bate C., Williams A. Simvastatin treatment prolongs the survival of scrapie-infected mice. Neuroreport 2007, 18(5):479-482.
37. Khansari N., Shakiba Y., Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pathol. Inflamm. Allergy Drug Discov. 2009, 3(1):73-80.
38. Kimberlin R.H., Walker C.A. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol. 1979, 89(4):551-562.
39. Kimberlin R.H., Walker C.A. The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res. 1989, 12(3):201-211.
40. Koch T.K., Berg B.O., De Armond S.J., Gravina R.F. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N. Engl. J. Med. 1985, 313(12):731-733.
41. Larbi A., Douziech N., Dupuis G., Khalil A., Pelletier H., Guerard K.P., Fulop T. Age-associated alterations in the recruitment of signal-transduction proteins to lipid rafts in human T lymphocytes. J. Leukoc. Biol. 2004, 75(2):373-381.
42. Lee C.K., Klopp R.G., Weindruch R., Prolla T.A. Gene expression profile of aging and its retardation by caloric restriction. Science 1999, 285(5432):1390-1393.
43. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 2000, 25(3):294-297.
44. Li W., Lesuisse C., Xu Y., Troncoso J.C., Price D.L., Lee M.K. Stabilization of alpha-synuclein protein with aging and familial Parkinson's disease-linked A53T mutation. J. Neurosci. 2004, 24(33):7400-7409.
45. Loring J.F., Wen X., Lee J.M., Seilhamer J., Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2001, 20(11):683-695.
46. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429(6994):883-891.
47. Maes O.C., Xu S., Yu B., Chertkow H.M., Wang E., Schipper H.M. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol. Aging 2007, 28(12):1795-1809.
48. Mallucci G., Dickinson A., Linehan J., Klohn P.C., Brandner S., Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003, 302(5646):871-874.
49. Marella M., Chabry J. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci. 2004, 24(3):620-627.
50. McLean C.A., Ironside J.W., Alpers M.P., Brown P.W., Cervenakova L., Anderson R.M., Masters C.L. Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol. (Zurich, Switzerland) 1998, 8(3):429-437.
51. McLennan N.F., Brennan P.M., McNeill A., Davies I., Fotheringham A., Rennison K.A., Ritchie D., Brannan F., Head M.W., Ironside J.W., Williams A., Bell J.E. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am. J. Pathol. 2004, 165(1):227-235.
52. McLennan N.F., Rennison K.A., Bell J.E., Ironside J.W. In situ hybridization analysis of PrP mRNA in human CNS tissues. Neuropathol. Appl. Neurobiol. 2001, 27(5):373-383.
53. Muramoto T., Kitamoto T., Tateishi J., Goto I. The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease. Am. J. Pathol. 1992, 140(6):1411-1420.
54. Muramoto T., Kitamoto T., Tateishi J., Goto I. Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. Am. J. Pathol. 1993, 143(5):1470-1479.
55. Nakanishi H. Neuronal and microglial cathepsins in aging and age-related diseases. Ageing Res. Rev. 2003, 2(4):367-381.
56. Naslavsky N., Stein R., Yanai A., Friedlander G., Taraboulos A. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J. Biol. Chem. 1997, 272(10):6324-6331.
57. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(23):13363-13383.
58. Prusiner S.B., Cochran S.P., Groth D.F., Downey D.E., Bowman K.A., Martinez H.M. Measurement of the scrapie agent using an incubation time interval assay. Ann. Neurol. 1982, 11(4):353-358.
59. Riemer C., Neidhold S., Burwinkel M., Schwarz A., Schultz J., Kratzschmar J., Monning U., Baier M. Gene expression profiling of scrapie-infected brain tissue. Biochem. Biophys. Res. Commun. 2004, 323(2):556-564.
60. Ritchie D.L., Boyle A., McConnell I., Head M.W., Ironside J.W., Bruce M.E. Transmissions of variant Creutzfeldt-Jakob disease from brain and lymphoreticular tissue show uniform and conserved BSE-related phenotypic properties on primary and secondary passage in wild-type mice. J. Gen. Virol. 2009.
61. Sohal R.S., Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996, 273(5271):59-63.
62. Spencer M.D., Knight R.S., Will R.G. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 2002, 324(7352):1479-1482.
63. Sun Y., Makarava N., Lee C.I., Laksanalamai P., Robb F.T., Baskakov I.V. Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J. Mol. Biol. 2008, 376(4):1155-1167.
64. Szakal A.K., Taylor J.K., Smith J.P., Kosco M.H., Burton G.F., Tew J.J. Kinetics of germinal center development in lymph nodes of young and aging immune mice. Anat. Rec. 1990, 227(4):475-485.
65. Tang Y., Xiang W., Hawkins S.A., Kretzschmar H.A., Windl O. Transcriptional changes in the brain of cattle orally infected with BSE precede detection of infectivity. J. Virol. 2009.
66. Van Everbroeck B., Dewulf E., Pals P., Lubke U., Martin J.J., Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol. Aging 2002, 23(1):59-64.
67. Will R.G. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br. Med. Bull. 2003, 66:255-265.
68. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P.G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996, 347(9006):921-925.
69. Williams W.M., Stadtman E.R., Moskovitz J. Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma. Neuropathol. Appl. Neurobiol. 2004, 30(2):161-168.
70. Xiang W., Windl O., Westner I.M., Neumann M., Zerr I., Lederer R.M., Kretzschmar H.A. Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 2005, 58(2):242-257.
71. Xiang W., Windl O., Wunsch G., Dugas M., Kohlmann A., Dierkes N., Westner I.M., Kretzschmar H.A. Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J. Virol. 2004, 78(20):11051-11060.
72. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., Doyu M., Sobue G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 2002, 80(1):158-167.
73. Zheng B., Han S., Takahashi Y., Kelsoe G. Immunosenescence and germinal center reaction. Immunol. Rev. 1997, 160:63-77.